On Monday, March 18, 2019, the Patent Trial and Appeal Board (PTAB) designated three decisions as precedential. Two of the three decisions—K40 Electronics LLC v. Escort Inc. (“K40 Electronics”),[AIA, live testimony at oral argument] and DePuy Synthes Products Inc. v. Medidea LLC (“DePuy Synthes Prods”) [AIA, live testimony at oral argument]—explained the limited circumstances in which live testimony may be allowed during PTAB proceedings. The third decision, Amazon.com Inc. v. Uniloc Luxembourg SA (“Amazon.com”) [AIA § 316(d), grounds that can be raised against substitute claims], affirmed that the PTAB has the authority to consider whether substitute claims are patentable on more grounds than just novelty and non-obviousness. The recent designations not only provide guidance to prospective litigants in PTAB proceedings, but develop the scope of PTAB litigation as a viable alternative to district court litigation.
What the PTAB’s Precedential Decisions on Live Testimony and Substitute Claims Mean for PTAB Litigation
No Comments
Litigation
- USPTO Precedential Opinion Panel Delivers Key Ruling for Inventors
- Key Points from Responses to Senator Hirono’s Questions to Section 101 Panelists
- As Stakeholders Await New 101 Bill, Responses to Tillis Underscore Need for Movement
- Federal Circuit Agrees That Argument-Based Prosecution Estoppel Barred Amgen from Succeeding on Infringement Claim
- Note to President Trump: Silicon Valley Pirates Are a Bigger Threat to Intellectual Property Than China
Recent Posts
- USPTO Precedential Opinion Panel Delivers Key Ruling for Inventors
- Key Points from Responses to Senator Hirono’s Questions to Section 101 Panelists
- As Stakeholders Await New 101 Bill, Responses to Tillis Underscore Need for Movement
- Creating a Home(work) Station That Gets Top Marks
- Federal Circuit Agrees That Argument-Based Prosecution Estoppel Barred Amgen from Succeeding on Infringement Claim